skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove subject: Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induce autophagic cell death in estrogen receptor negative breast cancer
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induce autophagic cell death in estrogen receptor negative breast cancer
Material Type:
Article 		Add to My Research

1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induce autophagic cell death in estrogen receptor negative breast cancer

BMC cancer, 2010-12, Vol.10 (1), p.669-669, Article 669 [Peer Reviewed Journal]

COPYRIGHT 2010 BioMed Central Ltd. ;2010 Vanderlaag et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2010 Vanderlaag et al; licensee BioMed Central Ltd. 2010 Vanderlaag et al; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-10-669 ;PMID: 21129193

Full text available

Citations Cited by
2
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
Material Type:
Article 		Add to My Research

17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells

BMC cancer, 2010-09, Vol.10 (1), p.481-481, Article 481 [Peer Reviewed Journal]

COPYRIGHT 2010 BioMed Central Ltd. ;COPYRIGHT 2010 BioMed Central Ltd. ;2010 Karkoulis et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2010 Karkoulis et al; licensee BioMed Central Ltd. 2010 Karkoulis et al; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-10-481 ;PMID: 20828379

Full text available

Citations Cited by
3
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
Material Type:
Article 		Add to My Research

5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells

BMC cancer, 2016-07, Vol.16 (1), p.458-458, Article 458 [Peer Reviewed Journal]

COPYRIGHT 2016 BioMed Central Ltd. ;COPYRIGHT 2016 BioMed Central Ltd. ;Copyright BioMed Central 2016 ;The Author(s). 2016 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-016-2499-3 ;PMID: 27411387

Full text available

Citations Cited by
4
A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019
A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019
Material Type:
Article 		Add to My Research

A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019

BMC cancer, 2021-02, Vol.21 (1), p.115-115, Article 115 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-07818-4 ;PMID: 33541299

Full text available

Citations Cited by
5
AB0 blood group and prognosis in patients with pancreatic cancer
AB0 blood group and prognosis in patients with pancreatic cancer
Material Type:
Article 		Add to My Research

AB0 blood group and prognosis in patients with pancreatic cancer

BMC cancer, 2012-07, Vol.12 (1), p.319-319, Article 319 [Peer Reviewed Journal]

COPYRIGHT 2012 BioMed Central Ltd. ;COPYRIGHT 2012 BioMed Central Ltd. ;2012 Rahbari et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Rahbari et al.; licensee BioMed Central Ltd. 2012 Rahbari et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-12-319 ;PMID: 22838843

Full text available

Citations Cited by
6
Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
Material Type:
Article 		Add to My Research

Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival

BMC cancer, 2022-04, Vol.22 (1), p.405-405, Article 405 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09481-9 ;PMID: 35421941

Full text available

Citations Cited by
7
Access to clinical trials among oncology patients: results of a cross sectional survey
Access to clinical trials among oncology patients: results of a cross sectional survey
Material Type:
Article 		Add to My Research

Access to clinical trials among oncology patients: results of a cross sectional survey

BMC cancer, 2017-09, Vol.17 (1), p.653-653, Article 653 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3644-3 ;PMID: 28923028

Full text available

Citations Cited by
8
Access to principal treatment centres and survival rates for children and young people with cancer in Yorkshire, UK
Access to principal treatment centres and survival rates for children and young people with cancer in Yorkshire, UK
Material Type:
Article 		Add to My Research

Access to principal treatment centres and survival rates for children and young people with cancer in Yorkshire, UK

BMC cancer, 2017-03, Vol.17 (1), p.168-168, Article 168 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3160-5 ;PMID: 28257637

Full text available

Citations Cited by
9
Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate Cancer: a systematic review and meta-analysis
Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate Cancer: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Accuracy of multiparametric magnetic resonance imaging for diagnosing prostate Cancer: a systematic review and meta-analysis

BMC cancer, 2019-12, Vol.19 (1), p.1244-1244, Article 1244 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6434-2 ;PMID: 31870327

Full text available

Citations Cited by
10
Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer
Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer
Material Type:
Article 		Add to My Research

Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer

BMC cancer, 2019-02, Vol.19 (1), p.160-160, Article 160 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5351-8 ;PMID: 30782151

Full text available

Citations Cited by
11
Achieving integrated self-directed Cancer aftercare (ASICA) for melanoma: how a digital intervention to support total skin self-examination was used by people treated for cutaneous melanoma
Achieving integrated self-directed Cancer aftercare (ASICA) for melanoma: how a digital intervention to support total skin self-examination was used by people treated for cutaneous melanoma
Material Type:
Article 		Add to My Research

Achieving integrated self-directed Cancer aftercare (ASICA) for melanoma: how a digital intervention to support total skin self-examination was used by people treated for cutaneous melanoma

BMC cancer, 2021-11, Vol.21 (1), p.1217-1217, Article 1217 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08959-2 ;PMID: 34774015

Full text available

Citations Cited by
12
ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
Material Type:
Article 		Add to My Research

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial

BMC cancer, 2019-11, Vol.19 (1), p.1117-7, Article 1117 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6289-6 ;PMID: 31729964

Full text available

Citations Cited by
13
Activation of pro-oncogenic pathways in colorectal hyperplastic polyps
Activation of pro-oncogenic pathways in colorectal hyperplastic polyps
Material Type:
Article 		Add to My Research

Activation of pro-oncogenic pathways in colorectal hyperplastic polyps

BMC cancer, 2013-11, Vol.13 (1), p.531-531, Article 531 [Peer Reviewed Journal]

COPYRIGHT 2013 BioMed Central Ltd. ;COPYRIGHT 2013 BioMed Central Ltd. ;2013 Do et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2013 Do et al.; licensee BioMed Central Ltd. 2013 Do et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-13-531 ;PMID: 24209454

Full text available

Citations Cited by
14
Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression
Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression
Material Type:
Article 		Add to My Research

Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression

BMC cancer, 2013-07, Vol.13 (1), p.343-343, Article 343 [Peer Reviewed Journal]

COPYRIGHT 2013 BioMed Central Ltd. ;COPYRIGHT 2013 BioMed Central Ltd. ;2013 Wang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2013 Wang et al.; licensee BioMed Central Ltd. 2013 Wang et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-13-343 ;PMID: 23848995

Full text available

Citations Cited by
15
Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial
Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial
Material Type:
Article 		Add to My Research

Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial

BMC cancer, 2021-01, Vol.21 (1), p.47-47, Article 47 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07652-0 ;PMID: 33430808

Full text available

Citations Cited by
16
Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice
Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice
Material Type:
Article 		Add to My Research

Adeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude mice

BMC cancer, 2012-04, Vol.12 (1), p.153-153, Article 153 [Peer Reviewed Journal]

COPYRIGHT 2012 BioMed Central Ltd. ;COPYRIGHT 2012 BioMed Central Ltd. ;2012 Liu et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Liu et al.; licensee BioMed Central Ltd. 2012 Liu et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-12-153 ;PMID: 22530952

Full text available

Citations Cited by
17
Adherence evaluation of endocrine treatment in breast cancer: methodological aspects
Adherence evaluation of endocrine treatment in breast cancer: methodological aspects
Material Type:
Article 		Add to My Research

Adherence evaluation of endocrine treatment in breast cancer: methodological aspects

BMC cancer, 2012-10, Vol.12 (1), p.474-474, Article 474 [Peer Reviewed Journal]

COPYRIGHT 2012 BioMed Central Ltd. ;COPYRIGHT 2012 BioMed Central Ltd. ;2012 Oberguggenberger et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2012 Oberguggenberger et al.; licensee BioMed Central Ltd. 2012 Oberguggenberger et al.; licensee BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/1471-2407-12-474 ;PMID: 23066928

Full text available

Citations Cited by
18
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
Material Type:
Article 		Add to My Research

Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival

BMC cancer, 2019-06, Vol.19 (1), p.569-10, Article 569 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5790-2 ;PMID: 31185957

Full text available

Citations Cited by
19
Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: a retrospective observational study with use of a national database in Japan
Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: a retrospective observational study with use of a national database in Japan
Material Type:
Article 		Add to My Research

Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: a retrospective observational study with use of a national database in Japan

BMC cancer, 2017-09, Vol.17 (1), p.613-613, Article 613 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3610-0 ;PMID: 28865438

Full text available

Citations Cited by
20
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
Material Type:
Article 		Add to My Research

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data

BMC cancer, 2019-05, Vol.19 (1), p.523-523, Article 523 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5740-z ;PMID: 31151419

Full text available

Citations Cited by
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2010  (25)
  2. 2010 To 2012  (231)
  3. 2013 To 2015  (248)
  4. 2016 To 2019  (444)
  5. After 2019  (754)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,700)
  2. Reviews  (1)
  3. More options open sub menu

Subject 

  1. Oncology  (1,602)
  2. Life Sciences & Biomedicine  (1,593)
  3. Science & Technology  (1,593)
  4. Humans  (1,275)
  5. Medical Research  (1,215)
  6. Care And Treatment  (883)
  7. Female  (870)
  8. Tumors  (662)
  9. Health Aspects  (662)
  10. Analysis  (657)
  11. Male  (639)
  12. Middle Aged  (624)
  13. Chemotherapy  (621)
  14. Patients  (620)
  15. Medicine, Experimental  (619)
  16. Cancer Therapies  (557)
  17. Prognosis  (550)
  18. Aged  (533)
  19. Adult  (486)
  20. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait